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Minimally invasive techniques are less 
traumatic compared to conventional approaches. 
Minimally invasive mitral valve surgery (MIMVS) 
has gained popularity in the last decade [1–3]. 
The routine use of MIMVS is associated with less 
surgical trauma, postoperative pain, blood loss, 
ventilation time, intensive care unit, and total 
hospital stay. This could lower the load on 
postoperative rehabilitation services, increase the 
turnover, and improve the postoperative cosmetic 
results.  In addition, it has lower postoperative 
complications compared to the conventional 
method [3–5]. 
It was found that the stress response in 
minimally invasive surgery is much less than the 
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Abstract 
Background: Minimally invasive mitral valve surgery (MIMVS) is associated with less 
surgical trauma. However, its advantages over the conventional approach are 
controversial. This study aims to compare the early postoperative pain, hospital stay, 
and pulmonary function between minimally invasive and conventional mitral repair. 
Methods: Fifty patients with non-ischemic mitral valve disease who had mitral valve 
repair between 2017 and 2019 were included in the study. Patients were randomly 
divided into two equal groups. Group A (n=25) included patients who had minimally 
invasive mitral valve repair via anterolateral mini-thoracotomy with video 
assistance, and Group B (n=25) included patients who had mitral valve repair via 
median sternotomy. 
Results: The cross-clamp (99.45±16.01 vs. 87. 5±19.16 min; p= 0.058) and the total 
bypass times (134.08±27.38 vs. 120.71±22.18 min; p= 0.35) were non-significantly 
longer in Group A. Operative time was significantly longer in Group A (207.08±44.31 
vs. 173.54±28.25 min; p= 0.001). The ICU stay in Group (A) was 2.58±1.44 days, and 
in Group (B), the ICU stay was 3.75±1.77 days (p= 0.001). The hospital stay was 
7.87±1.59 days in Group A, and 14.5 ±5.05 days in Group B (P<0.001). Postoperative 
FEV1 was 2.06±0.63 L in Group A and 1.39±0.43 L in Group B (p= 0.001). There was 
no difference in postoperative ejection fraction between both groups (p= 0.9). 
Conclusion: Minimal invasive mitral valve repair could reduce postoperative pain, 
length of ICU, and hospital stay and improve the postoperative respiratory function 
when compared to the conventional approach. 
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conventional approach. Stress hormones, 
including catecholamines, steroids, and thyroxin, 
were lower in patients who had minimally 
invasive surgeries [1,2,5,6]. 
Patient selection for MIMVS is crucial to avoid 
the risks of vascular complications caused by 
femoral cannulation and retrograde perfusion 
[3,5]. Mitral valve repair needs well-trained 
surgeons as well as optimal exposure and valve 
visualization to enable surgeons to make precise 
analyses and assessments of the diseased valve. 
Thus, in this study, we compared the early 
outcomes of minimally invasive mitral valve repair 
to the conventional approach. 
Patients and Methods: 
Study design 
This research is a randomized study conducted 
in the National Heart Institute, Giza, Egypt, from 
May 2017 till April 2019. The Ethical Committee 
approved the study, and informed patients’ 
consents were obtained.  
Inclusion Criteria 
We included 50 patients with non-ischemic 
mitral valve disease with or without tricuspid valve 
disease. We divided the patients randomly into 
two equal groups. Group A (n=25) included 
patients who had minimally invasive mitral valve 
repair via anterolateral mini-thoracotomy, and 
Group B (n=25) included patients who had mitral 
valve repair via median sternotomy.  
Exclusion Criteria 
We excluded patients who had concomitant 
surgery, redo sternotomy, or contraindications to 
femoral cannulation or peripheral vascular 
disorders. Additionally, we excluded patients who 
had prior right lung surgery or radiotherapy to the 
right side of the chest and impaired preoperative 
pulmonary function. 
Study data 
All patients had a preoperative examination, 
full laboratory investigations, echocardiography, 
and pulmonary function tests. Coronary 
angiography was performed when indicated. We 
recorded the type of repair, cardiopulmonary 
bypass and cross-clamp times, and operative 
complications. 
The amount of blood loss, duration of 
mechanical ventilation, ICU and hospital stay, 
postoperative complications, and postoperative 
pain severity were compared between groups. 
Surgical Technique: 
Induction of general anesthesia was 
performed with propofol, pancuronium, and 
fentanyl and maintained with propofol and 
fentanyl. In the MIMVS group, single-lung 
ventilation was used for all patients. 
The femoral cutdown technique was adopted 
for femoral cannulation for all patients. After the 
preparation of the groin, A transverse skin incision 
was made over the femoral vessels just below the 
inguinal ligament. After that, the dissection was 
performed to expose the femoral artery and vein; 
then, a purse-string (5-0) Gortex suture was 
placed. 
A femoral vein was punctured, then, the 
guidewire was passed through the introducer 
sheath and was introduced into the right atrium 
under echocardiographic guidance. The sheath 
was removed; venous cannula dilators were 
essential in tunneling the cannula path, then the 
venous cannula sized (23-25 Fr) multistage quick 
draw cannula was introduced over the guidewire 
until it reached the final position. The venous 
cannula was de-aired by partially unclamping and 
expelling blood before connecting to the venous 
line.  
The femoral artery was cannulated with (16-18 
Fr) Edward Femoral Cannula. Then a stay suture 
was placed on the skin as a tourniquet over the 
cannula body to secure it in place. 
The MIMVS group patients underwent right 
anterolateral mini-thoracotomy via the 4th 
intercostal space. Once the thoracotomy was 
performed, two working ports were made. The 
pericardial incision was performed with strict 
precautions to avoid phrenic nerve injury, so; we 
keep the incision 3-4 cm above the phrenic nerve. 
A standard cardioplegia catheter was placed in the 




Table 1: Demographic and Perioperative Data 
Group A (n= 25) Group B (n= 25) P-value 
Age Mean±SD 42.72±12.67 49.52±12.38 0.061 







BMI Mean±SD 28.48±4.82 28.08±4.15 0.754 





























































BMI = Body Mass Index; NYHA = New York Heart Association; AF = Atrial Fibrillation; COPD = Chronic 
Obstructive Lung Disease; EF = ejection fraction; LVESD = Left Ventricular End Systolic Diameter; LVEDD = 
Left Ventricular End Diastolic Diameter; LA = Left Atrium; PASP = Pulmonary Artery Systolic Pressure; 
FEV1 = Forced Expiratory Volume in the first second; FVC = Forced Vital Capacity. 
ascending aorta, and the infusion and venting lines 
were connected in the usual fashion. 
The aorta was clamped with the Chitwood 
clamp and inserted laterally in the 2nd intercostal 
space. Once the aortic cross-clamp was correctly 
placed, the antegrade cardioplegia with a single 
dose of the crystalloid solution was delivered. The 
temperature during cardiopulmonary bypass was 
maintained at 32° C. 
The left atriotomy was performed, and the 
mitral valve was exposed then the mitral valve 
evaluation was performed. 
Statistical analysis: 
Data were analyzed using the Statistical 
Package for Social Sciences (SPSS) software 
program (version 23) (IBM Corp, Armonk- NY. 
USA). The qualitative variables were recorded as 
frequencies and percentages and compared with 
the chi-square test or Fisher exact test when 
appropriate. The quantitative measures were 
presented as means ± standard deviation (SD) and 
were compared with student t-test. P-value < 0·05 
was considered significant. 
Results 
Patient characteristics and preoperative data 
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Table 2: Intra-operative Data 
Group A (n= 25) Group B (n= 25) P-Value 
CPB (min) 134.08±27.38 120.71±22.18 0.350 
Cross-clamp time (min) 99.45±16.01 87. 5±19.16 0.058 
Total operative time (min) 207.08±44.31 173.54±28.25 0.001 
Incision length(cm) 5.6±0.65 20.25±2.32 0.001 
Ventilation time (hs) 5.68±1.42 10.64±4.95 0.001 
Blood Loss (ml) 243.2±76.72 490.2±192.42 0.001 
Blood Transfusion (No. of patients) 2 (8%) 5 (20%) 0.159 



































CPB = Cardiopulmonary Bypass; ICU = Intensive Care Unit; FEV1 = Forced Expiratory Volume in the first 
second; FVC = Forced Vital Capacity EF = ejection fraction; LVESD = Left Ventricular End Systolic 
Diameter; LVEDD = Left Ventricular End Diastolic Diameter; LA = Left Atrium; PASP = Pulmonary Artery 
Systolic Pressure. 
valve repair; the Cosgrove band was used 24 
patients (48%) patients Edwards ring was used in 
26 patients. Twenty-three patients (46%) had a 
concomitant tricuspid valve repair via DeVaga 
segmental technique. (Table 2). Two cases 
required DC shock in the group (A) 8%, and four 
cases in the group (B) 16%. No patient was 
converted to median sternotomy. 
ICU Complications: 
ICU course was smooth with no special events 
and no mortality in both groups. One case had a 
chest infection in each group, and three patients 
(12%) had arrhythmia in Group A and four patients 
(16%) in Group B. 
Postoperative PFTs study: 
There was a significant difference in the FVC, 
FEV1, FVC % between both groups with the better 
postoperative pulmonary function of the 
minimally invasive group. (Table 2) 
Postoperative echocardiography Findings: 
Follow-up Echo showed no significant 
difference in ejection fraction, left ventricular 
internal dimensions, left atrial dimension, or 
pulmonary artery systolic pressure (PASP) 
between both groups 1-month postoperatively 
(Table 2). 
Postoperative pain: 
Postoperative pain score assessed with the 
visual analog scale was compared between the 
two groups. In Group A, the mean pain score in the 
5th postoperative day was 3.95± 1.54, while the 
pain score in Group B in the 5th postoperative day 
was 7.54± 1.47 (P= 0.001). 
Postoperative complications: 
In Group A, three patients (12%) had 
postoperative arrhythmias, wound infection 
occurred in one patient (4%), and one patient had 
ARDS (4%). In Group B, four patients (16%) had 
arrhythmias, and superficial wound infection 
occurred in three patients (12%), which involved 






had a complete heart block that required a 
permeant pacemaker. There was no statistically 
significant difference in the postoperative 
complications in both groups. 
Hospital stay in Group A ranged from 6 to 12 
days with a mean of 6.04±1.10 days, and in Group 
B, it was 6-21 days (11.04±3.93 days; p= 0.001). 
Discussion 
MIMVS was associated with less surgical 
trauma and better cosmetic results when 
compared to the conventional approach [7]. The 
improvement in endoscopic instruments and 
technology and the perfusion circuits made the 
transition inevitable. The Society of Thoracic 
Surgeons reported that 20% of all mitral valve 
surgeries are performed using minimally invasive 
techniques, and 50% are robotically assisted [8,9]. 
The preoperative characteristics of our patients 
were comparable to other studies [10–13]. 
The preoperative echocardiographic showed 
that in Group (A) there were 17 patients (68%) 
with isolated mitral valve disease, and eight 
patients (32%) had mitral and tricuspid valve 
disease. In Group (B) there were 10 cases (40%) 
with isolated mitral valve disease, and 15 patients 
(60%) had mitral and tricuspid valve disease.  The 
preoperative echocardiographic data were 
comparable between both groups and consistent 
with the published series [14,15]. The conversion 
rate to sternotomy was zero in our series, which 
is comparable to other studies [16]. 
All patients had normal preoperative 
respiratory function with no difference between 
both groups. Assessing the degree of respiratory 
dysfunction that can result from mitral disease is 
an essential preoperative investigation [17]. 
Minimally invasive surgery is associated with a 
smaller skin incision, similar to the finding of 
this study [13]. Reduction in the size of the incision 
was associated with lower pain score, shorter 
ICU and hospital stay, and earlier recovery 
with better patient's satisfaction [7,14,16]. 
The cross-clamp, total bypass, and operative 
times were longer in Group A. This could be 
attributed to the learning curve and the setup 
required for the minimally invasive approach. Falk 
and coworkers found that the cross-clamp time 
was significantly increased with MIMVS. Shinfield 
and coworkers reported a significantly longer 
cross-clamp time in the MIMVS at the beginning 
of the learning experience [18,19]. 
In our study, Group A had femoral cannulation 
of both femoral artery and vein.  The femoral 
cannulation was accessible in all patients, and we 
did not need any aortic cannulation. Femoral 
cannulation can be done via a percutaneous 
approach [20]. 
In our study, there were attempts for 
intraoperative extubation, which was done in four 
patients in Group A. The postoperative mechanical 
ventilation was longer in Group B. The reason for 
the delayed extubation in the group (B) is 
attributed to delayed conscious recovery in five 
patients, bleeding in two patients, and respiratory 
dysfunction in three patients.  
Other studies showed that postoperative 
mechanical ventilation was significantly lower in 
patients who had minimally invasive mitral valve 
surgery [13,16]. Glauber and coworkers reported 
in their study performed on 1604 patients, 78 
patients (4.9 %) of all patients need reexploration 
because of bleeding, 48 patients (4.2 %) in the 
mitral valve repair group, and 30 patients (6.4 %) 
in the mitral valve replacement group. Minimally 
invasive surgery was associated with lower 
bleeding and re-exploration [21]. 
In our study, the blood drainage was lower in 
Group A, and none of our patients required re-
exploration for bleeding, and we cannot comment 
on the incidence of reopening in both groups due 
to a limited number of patients. Other studies 
reported that the incidence of re-exploration after 
minimally invasive heart surgery is nearly 
negligible [22]. Additionally, the amount of blood 
transfusion required in group A was less. Holzhey 
and colleagues showed that blood units needed 
were 3.6±1.2 units in the MIMVS group while 4.6
± 1.6 units in the sternotomy group [9].  
The ICU stay was less in Group A, which could 






and good respiratory function. In a study by Shah 
and coworkers, the duration of ICU stay longer in 
the sternotomy group, and this is consistent with 
other studies [13,23–25]. 
Postoperative spirometry was performed for 
all patients. Group A had no significant reduction 
one month after surgery, denoting better 
postoperative pulmonary functions than the 
sternotomy group. Grossi and colleagues 
compared pulmonary function in patients who 
had a port-access coronary artery bypass versus 
the standard sternotomy. Pulmonary functions 
were better in the minimally invasive approach in 
the early postoperative period, and the 
difference persisted up to 6 months [26]. 
After discharge from the hospital, all patients 
had a follow-up echocardiography one month 
later with no difference between groups. The pain 
after sternotomy is relatively low. MIMVS offered 
less pain compared to sternotomy. In this study, 
the pain score was lower with MIMVS, which is 
consistent with other studies [4,27]. Improved 
postoperative pain may have an impact on the 
time required to return to normal activity.  
The complications reported in both groups 
were not statistically different. This may be due to 
a limited number of studied cases. Postoperative 
arrhythmia was related to the inflammatory 
response during surgery. Atrial fibrillation was 
lower in patients who had minimally invasive 
surgery compared to the standard sternotomy 
[9,28,29]. 
The postoperative wound infection was 
comparable between both groups. It was reported 
in other series that the rate of infection was lower 
in patients who had thoracotomy compared to 
sternotomy [13,24]. 
Conclusion 
Minimal invasive mitral valve repair could 
reduce postoperative pain, length of ICU, and 
hospital stay and improve the postoperative 
respiratory function when compared to the 
conventional approach. 
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